Clinical Trial Update: Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System [Phase 2]

View source ↗

Summary

Phase 2 trial update on a Hepatitis B vaccine regimen using HBsAg with GSK adjuvant system in healthy, HBV-naive adults; study status completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBsAg vaccine with GSK adjuvant system

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2019-01-04